Novartis – At Novartis, we are reimagining medicineĬlick here for the list of speakers and panelists.Ĭlick here for the program of the workshop.Ĭlick here for information regarding the venue.Ĭlick here for information regarding the organizers.
fresh-frozen tissues from patients were sent to Microsynth AG. HAYA Therapeutics – Pioneering next-generation therapies for fibrotic disease These data suggest the presence of both bacterial DNA as well as peptides in glioblastoma. For everyoneĪlnylam Pharmaceuticals – The leading RNAi therapeutics companyĪxolabs – Serving Oligonucleotide Therapeuticsīiogen– Caring deeply. Its main activities involve oligonucleotide synthesis, DNA/RNA. Versameb – The next generation of RNA therapeuticsĪlithea Genomics – Large-scale RNA sequencing. Microsynth is a leading European company in the field of nucleic acid synthesis and analysis. Skyhawk – Small molecule Therapeutics for Alternative modulation of RNA Roche – Doing now what patients need next Moderna Therapeutics – Pioneering mRNA technology We are grateful to our sponsors for their support for the summit. Of note, the following day (Friday, January 27, 2023) the traditional Swiss RNA Workshop takes place at the same venue. The program is designed to leave enough time to network. The program will consist of keynotes, panel discussions, presentations and a meet-the-talent session. of DNA was quantified and GAG production was normalised to DNA content. 22 hours ago &0183 &32 These data suggest the presence of both bacterial DNA as well as peptides in glioblastoma.
#Microsynth dna software
The first Swiss RNA Therapeutics Summit will take place on Thursday, January 26, 2023, from 08:30 – 18:00 at the UniS building of the University of Bern, which is located in close proximity to the Bern train station. the primer express design software V.1.5 and were synthesized by Microsynth. The Swiss RNA Therapeutics Summit is a joint initiative of the National Center of Competence in Research (NCCR) “RNA & Disease: The Role of RNA in Disease Mechanisms”and the Swiss Biotech Association. The idea of the workshop was born after a panel discussion on “RNA Drugs: Applications Beyond Vaccines”at the Swiss Biotech Day in May 2022 in Basel. Also, the workshop brings into together companies with potential future employees. The Swiss RNA Therapeutics Summit brings together stakeholders in the field of RNA Therapeutics from academia, biotechnology, pharma, manufacturing, government, and regulatory bodies with the aim to join forces in this rapidly advancing field.
0 kommentar(er)
